Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug resistance associated with altered DNA topoisomerase II.

× No keyword cloud information.

26 in total

1. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Authors: Natisha Magan; Agnieszka P Szremska; Richard J Isaacs; Kathryn M Stowell
Journal: Biochem J Date: 2003-09-15 Impact factor: 3.857

2. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors: A Kathleen McClendon; Neil Osheroff
Journal: Biochemistry Date: 2006-03-07 Impact factor: 3.162

Review 3. Targeting DNA topoisomerase II in cancer chemotherapy.

Authors: John L Nitiss
Journal: Nat Rev Cancer Date: 2009-04-20 Impact factor: 60.716

4. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.

Authors: M I Sandri; R J Isaacs; W M Ongkeko; A L Harris; I D Hickson; M Broggini; F Vikhanskaya
Journal: Nucleic Acids Res Date: 1996-11-15 Impact factor: 16.971

5. Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.

Authors: Birandra K Sinha
Journal: J Cancer Sci Ther Date: 2016-10-28

Review 6. Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells.

Authors: W T Beck; R Kim; M Chen
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

7. Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.

Authors: Ryan P Bender; Michael J Jablonksy; Mohammad Shadid; Ian Romaine; Norma Dunlap; Clemens Anklin; David E Graves; Neil Osheroff
Journal: Biochemistry Date: 2008-03-21 Impact factor: 3.162

Drug resistance associated with altered DNA topoisomerase II.